Obstet Gynecol Sci.  2014 Nov;57(6):534-538. 10.5468/ogs.2014.57.6.534.

Recurrent ovarian steroid cell tumor, not otherwise specified managed with debulking surgery, radiofrequency ablation, and adjuvant chemotherapy

• Kim JS
• Park SN
• Kim BR

• KMID: 2314023
• DOI: http://doi.org/10.5468/ogs.2014.57.6.534

Abstract

Steroid cell tumors, not otherwise specified, are infrequently encountered ovarian neoplasms, which constitute <0.1% of all ovarian tumors. Most of these tumors are unilateral, and almost one-third of all cases are reportedly malignant. However, because most of these tumors are diagnosed in the early stage, and do not recur or metastasize, little is known about their response to therapies such as chemotherapy or radiation. Here, we present a rare case of recurrent steroid cell tumor, not otherwise specified that showed a complete response after debulking surgery, radiofrequency ablation, and adjuvant chemotherapy.

Keyword

Adjuvant chemotherapy; Debulking surgery; Radiofrequency ablation; Recurrent steroid cell tumor

MeSH Terms

Catheter Ablation*
Chemotherapy, Adjuvant*
Drug Therapy
Ovarian Neoplasms

Figure

• 

  Fig. 1 (A) Preoperative abdominopelvic computed tomography shows 24-mm arterial well-enhancing mass at segment 5 of liver and 30-mm well-enhancing omental mass at paracolic gutter space. (B,C) Abdominopelvic computed tomography and positron emission tomography/computed tomography after the completion of treatment shows no definitive noticeable nodules and discrete fluorodeoxyglucose uptake noted at the peritoneal cavity and liver.

• 

  Fig. 2 (A) Steroid cell tumor, not otherwise specified composed of cells with abundant eosinophilic to clear cytoplasm. The cells have an appearance similar to adrenal cortical cells (H&E, ×200). (B) Diffuse nuclear and cytoplasmic staining for inhibin-a in steroid cell tumor (×200). (C) Diffuse nuclear and cytoplasmic staining for calretinin in steroid cell tumor (×200).

Reference

1. Young RH, Shully RE. Steroid cell tumors of the ovary. In : Fox H, Wells M, editors. Obstetrical and gynecological pathology. Edinburgh: Churchill Livingstone;2003. p. 845–856.

2. Reedy MB, Richards WE, Ueland F, Uy K, Lee EY, Bryant C, et al. Ovarian steroid cell tumors, not otherwise specified: a case report and literature review. Gynecol Oncol. 1999; 75:293–297.

3. Wang PH, Chao HT, Lee WL. Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary. Fertil Steril. 1998; 69:353–355.

4. Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified): a clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987; 11:835–845.

5. Taylor HB, Norris HJ. Lipid cell tumors of the ovary. Cancer. 1967; 20:1953–1962.

6. Harris AC, Wakely PE Jr, Kaplowitz PB, Lovinger RD. Steroid cell tumor of the ovary in a child. Arch Pathol Lab Med. 1991; 115:150–154.

7. Berek JS, Rinehart RD, Adams Hillard PJ, Adashi EY. Endocrine disorders. In : Novak E, Berek JS, editors. Novak's gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins;2004. p. 890–895.

8. Wang PH, Chao HT, Lee RC, Lai CR, Lee WL, Kwok CF, et al. Steroid cell tumors of the ovary: clinical, ultrasonic, and MRI diagnosis: a case report. Eur J Radiol. 1998; 26:269–273.

9. Clement PB, Young RH. Atlas of gynecologic surgical pathology. Philadelphia: WB Saunders;2000.

10. Deavers MT, Malpica A, Ordonez NG, Silva EG. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol. 2003; 22:162–167.

11. Wang PH, Chao HT, Liu RS, Cho YH, Ng HT, Yuan CC. Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation. Gynecol Oncol. 2001; 83:596–598.

12. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1987; 70:765–769.